MedPath
FDA Approval

Lamotrigine

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
August 3, 2020
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Lamotrigine(25 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Clinical Solutions Wholesale, LLC

Clinical Solutions Wholesale, LLC

Clinical Solutions Wholesale, LLC

078710347

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Lamotrigine

Product Details

NDC Product Code
58118-1111
Application Number
ANDA090170
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
August 3, 2020
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61UClass: IACT
LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5XClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
Code: U3H27498KSClass: ACTIBQuantity: 25 mg in 1 1
POVIDONE, UNSPECIFIEDInactive
Code: FZ989GH94EClass: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2Class: IACT
© Copyright 2025. All Rights Reserved by MedPath